Hepatitis B Foundation names Baruch S. Blumberg Prize winner

The Hepatitis B Foundation has awarded Stephen Urban, PhD, the 2023 Baruch S. Blumberg Prize for his development of bulevirtide, the first drug approved for the treatment of hepatitis D.“The entire hepatitis B/D community owes a tremendous debt to Dr. Urban for his conception, design and creation of new therapeutics for hepatitis B and D,…

FDA grants orphan drug designation to ZB131 for cholangiocarcinoma

The FDA granted orphan drug designation to ZB131 for treatment of cholangiocarcinoma, according to the agent’s manufacturer.ZB131 (ZielBio) is a monoclonal antibody with a high affinity and specificity for cancer-specific plectin. The cell surface protein — identified in a variety of malignancies — is associated with aggressive tumors and poor prognosis, according to a ZielBio-issued…